Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India
· Delayed Price · Currency is INR 910.85
-14.40 (-1.56%)
Jun 6, 2025, 3:29 PM IST
Aarti Pharmalabs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Net Income | 2,724 | 2,169 | 1,935 | 1,223 | -0.05 | Upgrade
|
| Depreciation & Amortization | 869.04 | 732.35 | 625.43 | 421.19 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -5.51 | 4.47 | -0.4 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 135.3 | - | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 12.81 | 10.68 | 15 | - | - | Upgrade
|
| Other Operating Activities | 435.08 | 475.51 | 237.64 | 223.3 | - | Upgrade
|
| Change in Accounts Receivable | -844.33 | -1,255 | -351.72 | -1,025 | 0.05 | Upgrade
|
| Change in Inventory | 552.79 | -396.64 | -1,267 | -559.92 | - | Upgrade
|
| Change in Accounts Payable | -569.13 | 433.48 | 1,302 | -718.62 | - | Upgrade
|
| Operating Cash Flow | 3,316 | 2,164 | 2,501 | -437.04 | - | Upgrade
|
| Operating Cash Flow Growth | 53.25% | -13.50% | - | - | - | Upgrade
|
| Capital Expenditures | -4,020 | -1,556 | -1,021 | -1,412 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -418.41 | -431.81 | -175.29 | - | - | Upgrade
|
| Investment in Securities | 228.34 | -188.53 | -391.23 | -0.73 | - | Upgrade
|
| Other Investing Activities | 71.47 | 30.74 | 9.77 | 24.86 | - | Upgrade
|
| Investing Cash Flow | -4,139 | -2,146 | -1,578 | -1,387 | - | Upgrade
|
| Short-Term Debt Issued | 278.61 | 499.94 | - | 2,723 | - | Upgrade
|
| Long-Term Debt Issued | 1,000 | - | - | - | - | Upgrade
|
| Total Debt Issued | 1,279 | 499.94 | - | 2,723 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -1,243 | - | - | Upgrade
|
| Long-Term Debt Repaid | -62 | -49.3 | - | - | - | Upgrade
|
| Total Debt Repaid | -62 | -49.3 | -1,243 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 1,217 | 450.64 | -1,243 | 2,723 | - | Upgrade
|
| Issuance of Common Stock | 0.04 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -317.19 | -181.25 | -181.25 | - | - | Upgrade
|
| Other Financing Activities | -245.12 | -172.15 | -210.52 | -119.59 | - | Upgrade
|
| Financing Cash Flow | 654.35 | 97.24 | -1,635 | 2,604 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | -169.01 | 115.14 | -711.52 | 779.41 | - | Upgrade
|
| Free Cash Flow | -704.76 | 607.5 | 1,480 | -1,849 | - | Upgrade
|
| Free Cash Flow Growth | - | -58.95% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -3.33% | 3.28% | 7.61% | -15.40% | - | Upgrade
|
| Free Cash Flow Per Share | -7.77 | 6.70 | 16.33 | -20.40 | - | Upgrade
|
| Cash Interest Paid | 245.12 | 172.15 | 210.52 | 3.4 | - | Upgrade
|
| Cash Income Tax Paid | 645.27 | 569.37 | 623.83 | 211.29 | - | Upgrade
|
| Levered Free Cash Flow | -2,192 | -521.96 | 940.76 | -6,998 | - | Upgrade
|
| Unlevered Free Cash Flow | -2,024 | -414.37 | 1,072 | -6,995 | - | Upgrade
|
| Change in Net Working Capital | 813.11 | 1,116 | 103.46 | 7,035 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.